Related references
Note: Only part of the references are listed.Mitochondria as multifaceted regulators of cell death
Florian J. Bock et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)
Multiple BCL2 mutations cooccurring with Gly101Val emerge in chronic lymphocytic leukemia progression on venetoclax
Piers Blombery et al.
BLOOD (2020)
TRAIL Receptors Serve as Stress-Associated Molecular Patterns to Promote ER-Stress-Induced Inflammation
Graeme P. Sullivan et al.
DEVELOPMENTAL CELL (2020)
Mitochondria-to-nucleus retrograde signaling drives formation of cytoplasmic chromatin and inflammation in senescence
Maria Grazia Vizioli et al.
GENES & DEVELOPMENT (2020)
Randomized placebo-controlled trial of emricasan for non-alcoholic steatohepatitis-related cirrhosis with severe portal hypertension
Guadalupe Garcia-Tsao et al.
JOURNAL OF HEPATOLOGY (2020)
Allosteric Regulation of BH3 Proteins in Bcl-xL Complexes Enables Switch-like Activation of Bax
Christian Bogner et al.
MOLECULAR CELL (2020)
The cell biology of mitochondrial membrane dynamics
Marta Giacomello et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)
The apoptosis inhibitor Bcl-xL controls breast cancer cell migration through mitochondria-dependent reactive oxygen species production
Margaux Bessou et al.
ONCOGENE (2020)
STING-dependent paracriny shapes apoptotic priming of breast tumors in response to anti-mitotic treatment
Steven Lohard et al.
NATURE COMMUNICATIONS (2020)
Secretion of Acid Sphingomyelinase and Ceramide by Endothelial Cells Contributes to Radiation-Induced Intestinal Toxicity
Daniela Leonetti et al.
CANCER RESEARCH (2020)
Mitochondrial DNA in inflammation and immunity
Joel S. Riley et al.
EMBO REPORTS (2020)
Double agents of cell death: novel emerging functions of apoptotic regulators
Heather M. Lamb
FEBS JOURNAL (2020)
N6-Deoxyadenosine Methylation in Mammalian Mitochondrial DNA
Ziyang Hao et al.
MOLECULAR CELL (2020)
Metabolites released from apoptotic cells act as tissue messengers
Christopher B. Medina et al.
NATURE (2020)
Gasdermin E suppresses tumour growth by activating anti-tumour immunity
Zhibin Zhang et al.
NATURE (2020)
Tumor cells suppress radiation-induced immunity by hijacking caspase 9 signaling
Chuanhui Han et al.
NATURE IMMUNOLOGY (2020)
Reactive oxygen species (ROS) as pleiotropic physiological signalling agents
Helmut Sies et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)
Discovery of IAP-recruiting BCL-XL PROTACs as potent degraders across multiple cancer cell lines
Xuan Zhang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Tumour Cell Secretome in Chemoresistance and Tumour Recurrence
Emma C. Madden et al.
TRENDS IN CANCER (2020)
Emricasan (IDN-6556) Lowers Portal Pressure in Patients With Compensated Cirrhosis and Severe Portal Hypertension
Guadalupe Garcia-Tsao et al.
HEPATOLOGY (2019)
Apoptotic Caspases Suppress Type I Interferon Production via the Cleavage of cGAS, MAVS, and IRF3
Xiaohan Ning et al.
MOLECULAR CELL (2019)
Pharmacological reactivation of MYC-dependent apoptosis induces susceptibility to anti-PD-1 immunotherapy
Heidi M. Haikala et al.
NATURE COMMUNICATIONS (2019)
Interleukin-1β Induces mtDNA Release to Activate Innate Immune Signaling via cGAS-STING
Lauren D. Aarreberg et al.
MOLECULAR CELL (2019)
Gasdermin pores permeabilize mitochondria to augment caspase-3 activation during apoptosis and inflammasome activation
Corey Rogers et al.
NATURE COMMUNICATIONS (2019)
Targeting Mitochondrial Structure Sensitizes Acute Myeloid Leukemia to Venetoclax Treatment
Xufeng Chen et al.
CANCER DISCOVERY (2019)
The TP53 Apoptotic Network Is a Primary Mediator of Resistance to BCL2 Inhibition in AML Cells
Tamilla Nechiporuk et al.
CANCER DISCOVERY (2019)
Bim escapes displacement by BH3-mimetic anti-cancer drugs by double-bolt locking both Bcl-XL and Bcl-2
Qian Liu et al.
ELIFE (2019)
Caspases in Cell Death, Inflammation, and Disease
Nina Van Opdenbosch et al.
IMMUNITY (2019)
Structures of BCL-2 in complex with venetoclax reveal the molecular basis of resistance mutations
Richard W. Birkinshaw et al.
NATURE COMMUNICATIONS (2019)
Mitochondrial Reprogramming Underlies Resistance to BCL-2 Inhibition in Lymphoid Malignancies
Romain Guieze et al.
CANCER CELL (2019)
Targeting tumor phenotypic plasticity and metabolic remodeling in adaptive cross-drug tolerance
Aaron Goldman et al.
SCIENCE SIGNALING (2019)
RIPK3 Activation Leads to Cytokine Synthesis that Continues after Loss of Cell Membrane Integrity
Susana L. Orozco et al.
CELL REPORTS (2019)
Destabilization of NOXA mRNA as a common resistance mechanism to targeted therapies
Joan Montero et al.
NATURE COMMUNICATIONS (2019)
Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins
Rumani Singh et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)
Interactions between cancer-associated fibroblasts and tumor cells promote MCL-1 dependency in estrogen receptor-positive breast cancers
K. Louault et al.
ONCOGENE (2019)
A selective BCL-XL PROTAC degrader achieves safe and potent antitumor activity
Sajid Khan et al.
NATURE MEDICINE (2019)
BCL2-Family Dysregulation in B-Cell Malignancies: From Gene Expression Regulation to a Targeted Therapy Biomarker
Benoit Tessoulin et al.
FRONTIERS IN ONCOLOGY (2019)
The pro-tumorigenic host response to cancer therapies
Yuval Shaked
NATURE REVIEWS CANCER (2019)
Resolvins suppress tumor growth and enhance cancer therapy
Megan L. Sulciner et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
IL-8 regulates the doxorubicin resistance of colorectal cancer cells via modulation of multidrug resistance 1 (MDR1)
Jing Du et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2018)
PUMA amplifies necroptosis signaling by activating cytosolic DNA sensors
Dongshi Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
BAK/BAX macropores facilitate mitochondrial herniation and mtDNA efflux during apoptosis
Kate McArthur et al.
SCIENCE (2018)
Apoptotic Tumor Cell-Derived Extracellular Vesicles as Important Regulators of the Onco-Regenerative Niche
Christopher D. Gregory et al.
FRONTIERS IN IMMUNOLOGY (2018)
Mitochondrial inner membrane permeabilisation enables mtDNA release during apoptosis
Joel S. Riley et al.
EMBO JOURNAL (2018)
Targeting Bcl-2 for the treatment of multiple myeloma
Cyrille Touzeau et al.
LEUKEMIA (2018)
Systematic mapping of BCL-2 gene dependencies in cancer reveals molecular determinants of BH3 mimetic sensitivity
Ryan S. Soderquist et al.
NATURE COMMUNICATIONS (2018)
Exploiting MCL1 Dependency with Combination MEK+MCL1 Inhibitors Leads to Induction of Apoptosis and Tumor Regression in KRAS-Mutant Non-Small Cell Lung Cancer
Varuna Nangia et al.
CANCER DISCOVERY (2018)
BH3-Mimetic Drugs: Blazing the Trail for New Cancer Medicines
Delphine Merino et al.
CANCER CELL (2018)
VDAC2 enables BAX to mediate apoptosis and limit tumor development
Hui San Chin et al.
NATURE COMMUNICATIONS (2018)
The Mitochondrial Apoptotic Effectors BAX/BAK Activate Caspase-3 and-7 to Trigger NLRP3 Inflammasome and Caspase-8 Driven IL-1 beta Activation
James E. Vince et al.
CELL REPORTS (2018)
Shiga Toxin/Lipopolysaccharide Activates Caspase-4 and Gasdermin D to Trigger Mitochondrial Reactive Oxygen Species Upstream of the NLRP3 Inflammasome
Jaye M. Platnich et al.
CELL REPORTS (2018)
A Placebo-Controlled, Multicenter, Double-Blind, Phase 2 Randomized Trial of the Pan-Caspase Inhibitor Emricasan in Patients with Acutely Decompensated Cirrhosis
Gautam Mehta et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY (2018)
E2F1 interacts with BCL-xL and regulates its subcellular localization dynamics to trigger cell death
Celine Vuillier et al.
EMBO REPORTS (2018)
Subcellular Localization and Dynamics of the Bcl-2 Family of Proteins
Nikolay Popgeorgiev et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2018)
BCL-2 family proteins: changing partners in the dance towards death
Justin Kale et al.
CELL DEATH AND DIFFERENTIATION (2018)
Necroptosis in development, inflammation and disease
Ricardo Weinlich et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2017)
Therapeutic targeting of necroptosis by Smac mimetic bypasses apoptosis resistance in acute myeloid leukemia cells
C. Safferthal et al.
ONCOGENE (2017)
Cellular Senescence Promotes Adverse Effects of Chemotherapy and Cancer Relapse
Marco Demaria et al.
CANCER DISCOVERY (2017)
DNA-Containing Exosomes Derived from Cancer Cells Treated with Topotecan Activate a STING- Dependent Pathway and Reinforce Antitumor Immunity
Yuichi Kitai et al.
JOURNAL OF IMMUNOLOGY (2017)
Mitochondrial permeabilization engages NF-κB-dependent anti-tumour activity under caspase deficiency
Evangelos Giampazolias et al.
NATURE CELL BIOLOGY (2017)
Innate immune sensing of cytosolic chromatin fragments through cGAS promotes senescence
Selene Gluck et al.
NATURE CELL BIOLOGY (2017)
BCL-XL directly modulates RAS signalling to favour cancer cell stemness
Sophie de Carne Trecesson et al.
NATURE COMMUNICATIONS (2017)
Signalling strength determines proapoptotic functions of STING
Muhammet F. Gulen et al.
NATURE COMMUNICATIONS (2017)
Cleavage of DFNA5 by caspase-3 during apoptosis mediates progression to secondary necrotic/pyroptotic cell death
Corey Rogers et al.
NATURE COMMUNICATIONS (2017)
Targeting the differential addiction to anti-apoptotic BCL-2 family for cancer therapy
Akane Inoue-Yamauchi et al.
NATURE COMMUNICATIONS (2017)
Initiation and execution mechanisms of necroptosis: an overview
Sasker Grootjans et al.
CELL DEATH AND DIFFERENTIATION (2017)
Dying cells actively regulate adaptive immune responses
Nader Yatim et al.
NATURE REVIEWS IMMUNOLOGY (2017)
Developmental Regulation of Mitochondria! Apoptosis by c-Myc Governs Age- and Tissue-Specific Sensitivity to Cancer Therapeutics
Kristopher A. Sarosiek et al.
CANCER CELL (2017)
Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice
Jianhui Chang et al.
NATURE MEDICINE (2016)
iBH3: simple, fixable BH3 profiling to determine apoptotic priming in primary tissue by flow cytometry
Jeremy Ryan et al.
BIOLOGICAL CHEMISTRY (2016)
BOK Is a Non-canonical BCL-2 Family Effector of Apoptosis Regulated by ER-Associated Degradation
Fabien Llambi et al.
CELL (2016)
Directly targeting the mitochondrial pathway of apoptosis for cancer therapy using BH3 mimetics - recent successes, current challenges and future promise
Kristopher A. Sarosiek et al.
FEBS JOURNAL (2016)
Inactivation of prosurvival Bcl-2 proteins activates Bax/Bak through the outer mitochondrial membrane
Katelyn L. O'Neill et al.
GENES & DEVELOPMENT (2016)
The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models
Andras Kotschy et al.
NATURE (2016)
Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia
Andrew W. Roberts et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Constitutive p53 heightens mitochondrial apoptotic priming and favors cell death induction by BH3 mimetic inhibitors of BCL-xL
J. Le Pen et al.
CELL DEATH & DISEASE (2016)
Tight Sequestration of BH3 Proteins by BCL-xL at Subcellular Membranes Contributes to Apoptotic Resistance
Jessie Pecot et al.
CELL REPORTS (2016)
DNA damage and the balance between survival and death in cancer biology
Wynand P. Roos et al.
NATURE REVIEWS CANCER (2016)
Safety, efficacy, and pharmacokinetics of navitoclax (ABT-263) in combination with erlotinib in patients with advanced solid tumors
Anthony W. Tolcher et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2015)
Safety, efficacy, and pharmacokinetics of navitoclax (ABT-263) in combination with irinotecan: results of an open-label, phase 1 study
Anthony W. Tolcher et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2015)
Drug-Induced Death Signaling Strategy Rapidly Predicts Cancer Response to Chemotherapy
Joan Montero et al.
CELL (2015)
Transfer of mitochondria via tunneling nanotubes rescues apoptotic PC12 cells
X. Wang et al.
CELL DEATH AND DIFFERENTIATION (2015)
Mitochondrial Genome Acquisition Restores Respiratory Function and Tumorigenic Potential of Cancer Cells without Mitochondrial DNA
An S. Tan et al.
CELL METABOLISM (2015)
Methylation-dependent loss of RIP3 expression in cancer represses programmed necrosis in response to chemotherapeutics
Gi-Bang Koo et al.
CELL RESEARCH (2015)
Limited Mitochondrial Permeabilization Causes DNA Damage and Genomic Instability in the Absence of Cell Death
Gabriel Ichim et al.
MOLECULAR CELL (2015)
Caspase-3 Promotes Genetic Instability and Carcinogenesis
Xinjian Liu et al.
MOLECULAR CELL (2015)
Fractional killing arises from cell-to-cell variability in overcoming a caspase activity threshold
Jeremie Roux et al.
MOLECULAR SYSTEMS BIOLOGY (2015)
Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death
Jianjin Shi et al.
NATURE (2015)
RIPK1 and NF-κB signaling in dying cells determines cross-priming of CD8+ T cells
Nader Yatim et al.
SCIENCE (2015)
Exploiting selective BCL-2 family inhibitors to dissect cell survival dependencies and define improved strategies for cancer therapy
Joel D. Leverson et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Modulation of radiochemoimmunotherapy-induced B16 melanoma cell death by the pan-caspase inhibitor zVAD- fmk induces anti-tumor immunity in a HMGB1-, nucleotide- and T-cell-dependent manner
N. Werthmoeller et al.
CELL DEATH & DISEASE (2015)
The NOXA-MCL1-BIM axis defines lifespan on extended mitotic arrest
Manuel D. Haschka et al.
NATURE COMMUNICATIONS (2015)
Temporally sequenced anticancer drugs overcome adaptive resistance by targeting a vulnerable chemotherapy-induced phenotypic transition
Aaron Goldman et al.
NATURE COMMUNICATIONS (2015)
Apoptotic Caspases Suppress mtDNA-Induced STING-Mediated Type I IFN Production
Michael J. White et al.
CELL (2014)
Apoptotic Caspases Prevent the Induction of Type I Interferons by Mitochondrial DNA
Anthony Rongvaux et al.
CELL (2014)
Metaxins 1 and 2, two proteins of the mitochondrial protein sorting and assembly machinery, are essential for Bak activation during TNF alpha triggered apoptosis
Pierre-Francois Cartron et al.
CELLULAR SIGNALLING (2014)
MITOCHONDRIAL REACTIVE OXYGEN SPECIES (ROS) AND ROS-INDUCED ROS RELEASE
Dmitry B. Zorov et al.
PHYSIOLOGICAL REVIEWS (2014)
Inflammasome activation leads to Caspase-1-dependent mitochondrial damage and block of mitophagy
Jiujiu Yu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Bcl-xL controls a switch between cell death modes during mitotic arrest
N. Bah et al.
CELL DEATH & DISEASE (2014)
Molecular Profiling of the Residual Disease of Triple-Negative Breast Cancers after Neoadjuvant Chemotherapy Identifies Actionable Therapeutic Targets
Justin M. Balko et al.
CANCER DISCOVERY (2014)
Targeting BCL-2 with the BH3 Mimetic ABT-199 in Estrogen Receptor-Positive Breast Cancer
Francois Vaillant et al.
CANCER CELL (2013)
Synthetic Lethal Interaction of Combined BCL-XL and MEK Inhibition Promotes Tumor Regressions in KRAS Mutant Cancer Models
Ryan B. Corcoran et al.
CANCER CELL (2013)
Preferential transfer of mitochondria from endothelial to cancer cells through tunneling nanotubes modulates chemoresistance
Jennifer Pasquier et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
Cells surviving fractional killing by TRAIL exhibit transient but sustainable resistance and inflammatory phenotypes
Deborah A. Flusberg et al.
MOLECULAR BIOLOGY OF THE CELL (2013)
BID Preferentially Activates BAK while BIM Preferentially Activates BAX, Affecting Chemotherapy Response
Kristopher A. Sarosiek et al.
MOLECULAR CELL (2013)
Bax Exists in a Dynamic Equilibrium between the Cytosol and Mitochondria to Control Apoptotic Priming
Barbara Schellenberg et al.
MOLECULAR CELL (2013)
Structure-guided design of a selective BCL-XL inhibitor
Guillaume Lessene et al.
NATURE CHEMICAL BIOLOGY (2013)
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
Andrew J. Souers et al.
NATURE MEDICINE (2013)
Decoding and unlocking the BCL-2 dependency of cancer cells
Philippe Juin et al.
NATURE REVIEWS CANCER (2013)
Targeting the B-Cell Lymphoma/Leukemia 2 Family in Cancer
Matthew S. Davids et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Navitoclax (ABT-263) Reduces Bcl-xL-Mediated Chemoresistance in Ovarian Cancer Models
Maureen Wong et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
Sensitization of BCL-2-expressing breast tumors to chemotherapy by the BH3 mimetic ABT-737
Samantha R. Oakes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
BCL2/BCL-XL inhibition induces apoptosis, disrupts cellular calcium homeostasis, and prevents platelet activation
Meike Vogler et al.
BLOOD (2011)
Multiple BH3 Mimetics Antagonize Antiapoptotic MCL1 Protein by Inducing the Endoplasmic Reticulum Stress Response and Up-regulating BH3-only Protein NOXA
Tina C. Albershardt et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Bax Activation by Engagement with, Then Release from, the BH3 Binding Site of Bcl-xL
F. Gautier et al.
MOLECULAR AND CELLULAR BIOLOGY (2011)
c-Myc dependent expression of pro-apoptotic Bim renders HER2-overexpressing breast cancer cells dependent on anti-apoptotic Mcl-1
Mario Campone et al.
MOLECULAR CANCER (2011)
Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7
Ingrid E. Wertz et al.
NATURE (2011)
Pretreatment Mitochondrial Priming Correlates with Clinical Response to Cytotoxic Chemotherapy
Triona Ni Chonghaile et al.
SCIENCE (2011)
Reversion of epigenetically mediated BIM silencing overcomes chemoresistance in Burkitt lymphoma
Jose A. Richter-Larrea et al.
BLOOD (2010)
Acquired resistance to ABT-737 in lymphoma cells that up-regulate MCL-1 and BFL-1
Derek Yecies et al.
BLOOD (2010)
Autocrine production of interleukin-6 confers cisplatin and paclitaxel resistance in ovarian cancer cells
Yue Wang et al.
CANCER LETTERS (2010)
Resistance to Caspase-Independent Cell Death Requires Persistence of Intact Mitochondria
Stephen W. G. Tait et al.
DEVELOPMENTAL CELL (2010)
BH3-Triggered Structural Reorganization Drives the Activation of Proapoptotic BAX
Evripidis Gavathiotis et al.
MOLECULAR CELL (2010)
The landscape of somatic copy-number alteration across human cancers
Rameen Beroukhim et al.
NATURE (2010)
Pannexin 1 channels mediate 'find-me' signal release and membrane permeability during apoptosis
Faraaz B. Chekeni et al.
NATURE (2010)
Bcl-XL represents a druggable molecular vulnerability during aurora B inhibitor-mediated polyploidization
O. Jameel Shah et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Concurrent up-regulation of BCL-XL and BCL2A1 induces approximately 1000-fold resistance to ABT-737 in chronic lymphocytic leukemia
Meike Vogler et al.
BLOOD (2009)
Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
Piyush B. Gupta et al.
CELL (2009)
MYC-induced myeloid leukemogenesis is accelerated by all six members of the antiapoptotic BCL family
L. J. Beverly et al.
ONCOGENE (2009)
Cancer cells display intra- and interline variation profound following prolonged exposure to antimitotic drugs
Karen E. Gascoigne et al.
CANCER CELL (2008)
BH3 profiling identifies three distinct classes of apoptotic blocks to predict response to ABT-737 and conventional chemotherapeutic agents
Jing Deng et al.
CANCER CELL (2007)
GAPDH and autophagy preserve survival after apoptotic cytochrome c release in the absence of caspase activation
Anna Colell et al.
CELL (2007)
TOM22, a core component of the mitochondria outer membrane protein translocation pore, is a mitochondrial receptor for the proapoptotic protein Bax
G. Bellot et al.
CELL DEATH AND DIFFERENTIATION (2007)
The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized
Mark F. van Delft et al.
CANCER CELL (2006)
Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members
Michael Certo et al.
CANCER CELL (2006)
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
T Oltersdorf et al.
NATURE (2005)
Nanotubular highways for intercellular organelle transport
A Rustom et al.
SCIENCE (2004)
VDAC2 inhibits BAK activation and mitochondrial apoptosis
EHY Cheng et al.
SCIENCE (2003)
Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics
A Letai et al.
CANCER CELL (2002)
MCL1 transgenic mice exhibit a high incidence of B-cell lymphoma manifested as a spectrum of histologic subtypes
P Zhou et al.
BLOOD (2001)
Proapoptotic BAX and BAK: A requisite gateway to mitochondrial dysfunction and death
MC Wei et al.
SCIENCE (2001)
The coordinate release of cytochrome c during apoptosis is rapid, complete and kinetically invariant
JC Goldstein et al.
NATURE CELL BIOLOGY (2000)
Share Paper
